human | Q5 |
P6178 | Dimensions author ID | 011265750357.58 |
P496 | ORCID iD | 0000-0002-9331-3705 |
P1153 | Scopus author ID | 7102129339 |
P10861 | Springer Nature person ID | 011265750357.58 |
P69 | educated at | Harvard Medical School | Q49121 |
P108 | employer | National Institutes of Health | Q390551 |
P734 | family name | Morse | Q13571164 |
Morse | Q13571164 | ||
Morse | Q13571164 | ||
P735 | given name | Herbert | Q4926833 |
Herbert | Q4926833 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q30561836 | (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib. |
Q36384647 | A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling |
Q72115602 | A cell-surface antigen shared by B cells and Ly2+ peripheral T cells |
Q28215868 | A critical role for IL-21 in regulating immunoglobulin production |
Q37083674 | A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice |
Q45341202 | A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation |
Q30490198 | A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas |
Q35102250 | A novel isoform of the Ly108 gene ameliorates murine lupus. |
Q33992579 | A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation |
Q41555046 | A search for hapten-binding mouse plasmacytoma proteins |
Q31138227 | A three-stage framework for gene expression data analysis by L1-norm support vector regression |
Q46861217 | AID is required for germinal center-derived lymphomagenesis |
Q36274840 | ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans |
Q47153776 | ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells |
Q52025812 | Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of the IFN-gamma gene. |
Q70338853 | Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu |
Q69902903 | Allelic variants of Ly-5 in inbred and natural populations of mice |
Q34960188 | Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model |
Q71612543 | Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection |
Q36983562 | An ENU-induced mutation in the lymphotoxin alpha gene impairs organogenesis of lymphoid tissues in C57BL/6 mice |
Q36154339 | Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice |
Q79961185 | Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells |
Q33992633 | Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen |
Q53530923 | Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis. |
Q38297327 | Axon growth and guidance genes identify T-dependent germinal centre B cells |
Q35622991 | B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders |
Q24531276 | BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma |
Q48731693 | Bethesda proposals for classification of lymphoid neoplasms in mice |
Q74314309 | Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice |
Q45846498 | Biologic and molecular genetic characteristics of a unique MCF virus that is highly leukemogenic in ecotropic virus-negative mice |
Q36376081 | Burkitt lymphoma in the mouse. |
Q34470376 | CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells |
Q81504522 | Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale |
Q73414223 | Cells of the marginal zone--origins, function and neoplasia |
Q36057221 | Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms |
Q34358833 | Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis |
Q70120748 | Characterization of ecotropic murine leukemia viruses in SJL/J mice |
Q35057746 | Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1. |
Q71596217 | Chromosome 1 locus required for induction of CTL to H-2-compatible cells in NZB mice |
Q30176319 | Cloning, expression and genetic mapping of the mouse SH3 domain protein, SH3D2B. |
Q73990348 | Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice |
Q42974567 | Comment on "Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappa B-dependent cytokine expression in fibroblasts". |
Q40377860 | Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes |
Q36637580 | Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas |
Q41666755 | Contribution of B cell subsets to delayed development of MAIDS in xid mice |
Q34243327 | Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases |
Q37551315 | Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms |
Q36600941 | Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection. |
Q57281073 | Cytokine-dependent Modulation of Oral Tolerance in a Murine Model of Autoimmune Uveitis |
Q35144330 | Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice |
Q51588100 | Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. |
Q37350374 | Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments |
Q71181282 | Differential expression of two distinct xenotropic viruses in NZB mice |
Q38314895 | Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS. |
Q36237736 | Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias |
Q24540383 | Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma |
Q35849088 | Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation |
Q35055386 | Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. |
Q33588550 | Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK/STAT and AKT signaling in mouse plasmacytomas |
Q68956744 | Effect of xid on autoimmune C3H-gld/gld mice |
Q39102656 | Effects of antithymocyte serum on lymph node cells participating in the graft-vs-host reaction |
Q42616132 | Effects of immunization with the p12 proteins of LP-BM5 defective and ecotropic viruses on development of MAIDS. |
Q33975178 | Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility |
Q37414718 | Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma |
Q68413535 | Establishment of a molecular genetic map of distal mouse chromosome 1: further definition of a conserved linkage group syntenic with human chromosome 1q |
Q40484651 | Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia |
Q36399625 | Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl |
Q34482189 | Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas |
Q33826503 | Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS. |
Q47886851 | Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages |
Q36471271 | Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions |
Q40381482 | Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas |
Q36341407 | Expression of xenotropic murine leukemia viruses as cell-surface gp70 in genetic crosses between strains DBA/2 and C57BL/6 |
Q36372990 | Finding mouse models of human lymphomas and leukemia's using the Jackson laboratory mouse tumor biology database. |
Q35641616 | Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation |
Q33967749 | Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF |
Q33579495 | Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts |
Q44119035 | Genetic and functional relationships of the retroviral and lymphocyte alloantigen loci on mouse chromosome 1. |
Q73442827 | Genetic mapping in the mouse of Kif4, a gene encoding a kinesin-like motor protein |
Q40698857 | Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations |
Q38496006 | Genomic organisation and expression of BCL6 in murine B-cell lymphomas |
Q37374649 | Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. |
Q41780293 | Greying with age in mice: relation to expression of murine leukemia viruses |
Q24805062 | HLA class I and II genotype of the NCI-60 cell lines |
Q54711594 | High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. |
Q38320048 | Histologic and molecular characterizations of megakaryocytic leukemia in mice |
Q33828914 | Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC |
Q63309966 | ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells |
Q24672345 | ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells |
Q28304270 | ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells |
Q37142588 | IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. |
Q37380904 | IFN regulatory factor 8 regulates MDM2 in germinal center B cells |
Q36121801 | IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools |
Q37253871 | IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice |
Q33706389 | IL-6 and MYC collaborate in plasma cell tumor formation in mice |
Q34009997 | IL-6 transgenic mouse model for extraosseous plasmacytoma |
Q34077874 | IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells |
Q36969752 | IRF8 regulates B-cell lineage specification, commitment, and differentiation |
Q33579478 | IRF8 regulates myeloid and B lymphoid lineage diversification |
Q24301583 | Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters |
Q35018604 | Identification of candidate B-lymphoma genes by cross-species gene expression profiling |
Q44897414 | Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays |
Q37164431 | Identification of murine B cell lines that undergo somatic hypermutation focused to A:T and G:C residues |
Q28138098 | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein |
Q24647660 | Immunoglobulin class switch recombination is impaired in Atm-deficient mice |
Q72087141 | Immunologic function and cell surface antigen expression of lymphocytes of dystrophic mice |
Q54163883 | Impact of MHC class I gene on resistance to murine AIDS. |
Q70057265 | In vivo effects of antithymocyte serum on the homing patterns and graft-versus-host reactivity of murine splenic lymphocytes |
Q36364205 | In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). |
Q52908239 | Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. |
Q33230666 | Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120. |
Q44304252 | Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells |
Q36377433 | Induction of murine acquired immunodeficiency syndrome (MAIDS) in allophenic mice generated from strains susceptible and resistant to disease. |
Q53625915 | Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. |
Q28115493 | Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR |
Q33625352 | Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies |
Q40670824 | Lack of B-cell participation in acute lymphocyte choriomeningitis disease of the central nervous system |
Q37397836 | Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks |
Q33808602 | Lymphomas and high-level expression of murine leukemia viruses in CFW mice. |
Q36053048 | MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis |
Q69916163 | Mapping of the Ly-4 (L3T4) T-cell differentiation antigen on mouse chromosome 6 by the use of RFLPs in an interspecific cross |
Q33302468 | Mechanism-dependent selection of immunoglobulin gene library for obtaining covalent biocatalysts. |
Q85699304 | Mechanisms in B-cell neoplasia |
Q54208642 | Mice with an acquired immunodeficiency (MAIDS) develop a persistent infection after injection with Listeria monocytogenes. |
Q61659077 | Molecular phylogeny of Fv1 |
Q36553232 | Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses |
Q36079387 | Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation |
Q34254602 | Msh6 protects mature B cells from lymphoma by preserving genomic stability |
Q42832834 | Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. |
Q39579821 | Murine hematopoietic cell surface antigen expression |
Q33567153 | NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas |
Q74624557 | New genes involved in cancer identified by retroviral tagging |
Q33779715 | Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis |
Q73893212 | Non-Hodgkin lymphomas of mice |
Q36187330 | Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus |
Q68092434 | Organization of lymphocyte plasma membrane. Surface protein-membrane matrix interactions in B-cell lines of different stages of differentiation |
Q81534808 | Overexpression of Eg5 causes genomic instability and tumor formation in mice |
Q35006755 | PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells |
Q24294582 | PNPASE regulates RNA import into mitochondria |
Q54531867 | Pathogenesis of paralysis and lymphoma associated with a wild mouse retrovirus infection. Part 1. Age- and dose-related effects in susceptible laboratory mice. |
Q48725591 | Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS. |
Q37399276 | Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice |
Q36375180 | Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein |
Q94042443 | Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein |
Q36227838 | Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein |
Q39159701 | Relationship between a retroviral germ line reintegration and a new mutation at the ashen locus in B10.F mice. Retroviral integration and an ashen mutation |
Q54251519 | Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4+ T Cell Polarization. |
Q41137358 | Role of IL12 in MAIDS. |
Q30838921 | Routes to covalent catalysis by reactive selection for nascent protein nucleophiles |
Q34346696 | SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy |
Q36208548 | Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. |
Q36376661 | Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma |
Q36973651 | T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation |
Q37692413 | TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice |
Q24607229 | TRIM family proteins and their emerging roles in innate immunity |
Q37546025 | Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss |
Q34552582 | The 3'-5' DNA exonuclease TREX1 directly interacts with poly(ADP-ribose) polymerase-1 (PARP1) during the DNA damage response |
Q70983912 | The B cell alloantigen Ly-17.1 is controlled by a gene closely linked to Ly-20 and Ly-9 on chromosome 1 |
Q36445813 | The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse |
Q74643155 | The Bcl6 locus is not mutated in mouse B-cell lineage lymphomas |
Q35669218 | The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. |
Q72077749 | The cytotoxic T-cell response to H-1 minor histocompatibility antigen differences |
Q48447724 | The encephalopathy associated with murine acquired immunodeficiency syndrome |
Q36125997 | The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. |
Q43334839 | The influence of a targeted deletion of the IFNgamma gene on emotional behaviors |
Q80034795 | The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity |
Q33747803 | The structural complexity of the human BORIS gene in gametogenesis and cancer |
Q33927253 | The transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation |
Q34375208 | The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation |
Q35144879 | Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter |
Q24616336 | Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation |
Q69041584 | Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO |
Q24316949 | c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene |
Search more.